Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, October 22, 2014
 
Register | Sign in
Home Page>Products
  Product News
BioDiscovery Launches NxClinical™ Software
Wednesday, October 22, 2014
A unique solution for complete case review and reporting for genetics labs.

Magritek’s Benchtop NMR Used in Undergrad Teaching Program
Wednesday, October 22, 2014
Company’s Spinsolve Benchtop NMR spectrometer used at Long Beach City College under Dr Marlon Jones leadership.

Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.

New Orbitrap-Based Mass Spectrometer
Tuesday, October 21, 2014
Makes high-resolution accurate-mass analysis widely accessible.

Bosch Debuts Flow Wrapper for Packaging Individual Vials in North America
Tuesday, October 21, 2014
Hermetic packaging for excellent product protection.

DNA Sequencing Analysis Kits Added to HIPAA Compliant Maverix Analytic Platform
Monday, October 20, 2014
Highly scalable analysis solutions for large volumes of whole genome, exome, and targeted resequencing data.

Syngene Launches World’s First Remote Access Blot and Gel Imager
Monday, October 20, 2014
T:Genius saves time by letting researchers see results anywhere, anytime.

Illumina Launches New Reagent Kits for HiSeq X Ten and HiSeq 2500 Systems
Saturday, October 18, 2014
Enhancements offer improved performance for high throughput sequencing.

Versatile Evaporator for Lab & Batch Processing Tasks
Friday, October 17, 2014
New Rocket Synergy series offers automated evaporation of a wide range of sample formats and sizes.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 10582
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv